229 related articles for article (PubMed ID: 11371496)
1. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG
Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496
[TBL] [Abstract][Full Text] [Related]
2. Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression.
Baker JK; Elshaw SR; Mathewman GE; Nichols CE; Murray AK; Parsons MA; Rennie IG; Sisley K
Melanoma Res; 2001 Jun; 11(3):265-73. PubMed ID: 11468515
[TBL] [Abstract][Full Text] [Related]
3. Molecular role(s) for integrins in human melanoma invasion.
Seftor RE; Seftor EA; Hendrix MJ
Cancer Metastasis Rev; 1999; 18(3):359-75. PubMed ID: 10721490
[TBL] [Abstract][Full Text] [Related]
4. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
5. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium.
Woodward JK; Rennie IG; Burn JL; Sisley K
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321
[TBL] [Abstract][Full Text] [Related]
6. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
7. Expression of VLA-2, VLA-3, and alpha(v) integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic value.
Anastassiou G; Schilling H; Djakovic S; Bornfeld N
Br J Ophthalmol; 2000 Aug; 84(8):899-902. PubMed ID: 10906100
[TBL] [Abstract][Full Text] [Related]
8. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
Alyahya GA
Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
[TBL] [Abstract][Full Text] [Related]
9. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
10. Invasive and noninvasive uveal melanomas have different adhesive properties.
Woodward JK; Rennie IG; Elshaw SR; Burn JL; Sisley K
Eye (Lond); 2005 Mar; 19(3):342-8. PubMed ID: 15258612
[TBL] [Abstract][Full Text] [Related]
11. Studies on primary uveal and cutaneous melanoma cell interaction with vitronectin.
Janik ME; Lityńska A; Przybyło M
Cell Biol Int; 2014 Aug; 38(8):942-52. PubMed ID: 24687613
[TBL] [Abstract][Full Text] [Related]
12. Integrin expression in uveal melanoma differs from cutaneous melanoma.
ten Berge PJ; Danen EH; van Muijen GN; Jager MJ; Ruiter DJ
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3635-40. PubMed ID: 8258522
[TBL] [Abstract][Full Text] [Related]
13. CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.
Lüke J; Vukoja V; Brandenbusch T; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Tura A
BMC Ophthalmol; 2016 Jun; 16():74. PubMed ID: 27255356
[TBL] [Abstract][Full Text] [Related]
14. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
[TBL] [Abstract][Full Text] [Related]
15. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
16. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
Sahin A; Kiratli H; Soylemezoglu F; Tezel GG; Bilgic S; Saracbasi O
Jpn J Ophthalmol; 2007; 51(5):325-331. PubMed ID: 17926107
[TBL] [Abstract][Full Text] [Related]
19. Beta1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility.
Przybyło M; Pocheć E; Link-Lenczowski P; Lityńska A
Mol Vis; 2008 Mar; 14():625-36. PubMed ID: 18385798
[TBL] [Abstract][Full Text] [Related]
20. Altered expression and function of beta1 integrins in a highly metastatic human lung adenocarcinoma cell line.
Takenaka K; Shibuya M; Takeda Y; Hibino S; Gemma A; Ono Y; Kudoh S
Int J Oncol; 2000 Dec; 17(6):1187-94. PubMed ID: 11078804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
